Pacer Advisors, Inc. Avrobio, Inc. Transaction History

Pacer Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$7.84 - $12.6 $18,165 - $29,194	-2,317 Closed	0 $0
Q1 2021 Apr 05, 2021	BUY	$10.54 - $19.3 $11,804 - $21,616	1,120 Added 93.57%	2,317 $29,000
Q4 2020 Jan 20, 2021	BUY	$12.79 - $17.1 $1,995 - $2,667	156 Added 14.99%	1,197 $17,000
Q3 2020 Oct 19, 2020	BUY	$12.99 - $19.41 $13,522 - $20,205	1,041 New	1,041 $14,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.